Transurethral holmium laser vaporization to the urethral tumour through a ureteroscope

Authors

  • Aihua Li Yangpu Hospital, School of Medicine, Tongji University
  • Wei Fang
  • Xiaoming Zuo
  • Feng Zhang
  • Weiwu Li
  • Honghai Lu
  • Sikuan Liu
  • Hui Wang
  • Binghui Zhang

DOI:

https://doi.org/10.5489/cuaj.2026

Keywords:

Urethral Tumor, Bladder tumor, Holmium Laser Vaporization, TURD-Bt, Efficancy

Abstract

We present 2 cases of urethral cancers: one is recurrent bladder transitional cell carcinoma accompanied by urethral metastatic carcinoma located on the right side of verumontanum, and the other is primary bladder and metastatic urethral adenocarcinoma. The urethral tumour was treated by transurethral holmium laser vaporization to the urethral tumour through a ureteroscope and the bladder tumour was treated with transurethral resection and degeneration of the bladder tumour (TURD-Bt). After the second or third therapy, patients were free of urethral or bladder tumour recurrence; they also did not experience urethral stricture or urinary incontinence during the 24- to 36-month follow-up. Transurethral holmium laser vaporization and TURD-Bt could be performed to treat non-invasive urethral cancer accompanied with bladder cancer and preserve the urethra and bladder.

Downloads

Download data is not yet available.

Downloads

Published

2014-12-15

How to Cite

Li, A., Fang, W., Zuo, X., Zhang, F., Li, W., Lu, H., Liu, S., Wang, H., & Zhang, B. (2014). Transurethral holmium laser vaporization to the urethral tumour through a ureteroscope. Canadian Urological Association Journal, 8(11-12), e913–5. https://doi.org/10.5489/cuaj.2026